Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial
Poveda, A., Vergote, I., Tjulandin, S., Kong, B., Roy, M., Chan, S., Filipczyk-Cisarz, E., Hagberg, H., Kaye, S.B., Colombo, N., Lebedinsky, C., Parekh, T., Gómez, J., Park, Y.C., Alfaro, V., Monk, B.J.
Published in Annals of oncology (01.01.2011)
Published in Annals of oncology (01.01.2011)
Get full text
Journal Article
Wnt signaling in ovarian tumorigenesis
Gatcliffe, T A, Monk, B J, Planutis, K, Holcombe, R F
Published in International journal of gynecological cancer (01.09.2008)
Published in International journal of gynecological cancer (01.09.2008)
Get full text
Journal Article
A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer
Vercellino, G. F., Erdemoglu, E., Lichtenberg, P., Muallem, M. Z., Richter, R., Abu-Rustum, N. R., Plante, M., Lécuru, F., Greggi, S., Monk, B. J., Sagae, S., Denkert, C., Keller, M., Alhakeem, M., Hellriegel, M., Dückelmann, A. M., Chiantera, V., Sehouli, Jalid
Published in Archives of gynecology and obstetrics (01.07.2019)
Published in Archives of gynecology and obstetrics (01.07.2019)
Get full text
Journal Article
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
Kaye, S.B., Colombo, N., Monk, B.J., Tjulandin, S., Kong, B., Roy, M., Chan, S., Filipczyk-Cisarz, E., Hagberg, H., Vergote, I., Lebedinsky, C., Parekh, T., Santabárbara, P., Park, Y.C., Nieto, A., Poveda, A.
Published in Annals of oncology (01.01.2011)
Published in Annals of oncology (01.01.2011)
Get full text
Journal Article
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
PETERS, W. A, LIU, P. Y, BARRETT, R. J, STOCK, R. J, MONK, B. J, BEREK, J. S, SOUHAMI, L, GRIGSBY, P, GORDON, W. JR, ALBERTS, D. S
Published in Journal of clinical oncology (01.04.2000)
Published in Journal of clinical oncology (01.04.2000)
Get full text
Journal Article
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I
Moore, K.N., Oza, A.M., Colombo, N., Oaknin, A., Scambia, G., Lorusso, D., Konecny, G.E., Banerjee, S., Murphy, C.G., Tanyi, J.L., Hirte, H., Konner, J.A., Lim, P.C., Prasad-Hayes, M., Monk, B.J., Pautier, P., Wang, J., Berkenblit, A., Vergote, I., Birrer, M.J.
Published in Annals of oncology (01.06.2021)
Published in Annals of oncology (01.06.2021)
Get full text
Journal Article
Treatment of patients with recurrent epithelial ovarian cancer for whom platinum is still an option
Buechel, M., Herzog, T.J., Westin, S.N., Coleman, R.L., Monk, B.J., Moore, K.N.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
Tewari, K.S., Java, J.J., Eskander, R.N., Monk, B.J., Burger, R.A.
Published in Annals of oncology (01.01.2016)
Published in Annals of oncology (01.01.2016)
Get full text
Journal Article
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
Bogani, G., Monk, B.J., Powell, M.A., Westin, S.N., Slomovitz, B., Moore, K.N., Eskander, R.N., Raspagliesi, F., Barretina-Ginesta, M.-P., Colombo, N., Mirza, M.R.
Published in Annals of oncology (01.05.2024)
Published in Annals of oncology (01.05.2024)
Get full text
Journal Article
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer
Vergote, I, du Bois, A, Floquet, A, Rau, J, Kim, J.-W, del Campo, J.M, Friedlander, M, Pignata, S, Fujiwara, K, Colombo, N, Mirza, M.R, Monk, B.J, Tsibulak, I, Calvert, P.M, Herzog, T.J, Hanker, L.C, Meunier, J, Lee, J.-Y, Bologna, A, Carrasco-Alfonso, M.J, Harter, P
Published in Gynecologic oncology (01.11.2019)
Published in Gynecologic oncology (01.11.2019)
Get full text
Journal Article
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3
CHAN, J. K, MONK, B. J, BERMAN, M. L, BREWER, C, KEEFE, K. A, OSANN, K, MCMEEKIN, S, ROSE, G. S, YOUSSEF, M, WILCZYNSKI, S. P, MEYSKENS, F. L
Published in British journal of cancer (15.09.2003)
Published in British journal of cancer (15.09.2003)
Get full text
Journal Article
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
Monk, B.J., Brady, M.F., Aghajanian, C., Lankes, H.A., Rizack, T., Leach, J., Fowler, J.M., Higgins, R., Hanjani, P., Morgan, M., Edwards, R., Bradley, W., Kolevska, T., Foukas, P., Swisher, E.M., Anderson, K.S., Gottardo, R., Bryan, J.K., Newkirk, M., Manjarrez, K.L., Mannel, R.S., Hershberg, R.M., Coukos, G.
Published in Annals of oncology (01.05.2017)
Published in Annals of oncology (01.05.2017)
Get full text
Journal Article
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)
Pothuri, B., Blank, S.V., Myers, T.K., Hines, J.F., Randall, L.M., O'Cearbhaill, R.E., Slomovitz, B.M., Eskander, R.N., Alvarez Secord, A., Coleman, R.L., Walker, J.L., Monk, B.J., Moore, K.N., O'Malley, D.M., Copeland, L.J., Herzog, T.J.
Published in Gynecologic oncology (01.07.2023)
Published in Gynecologic oncology (01.07.2023)
Get full text
Journal Article
Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study
Monk, B.J., Ghatage, P., Parekh, T., Henitz, E., Knoblauch, R., Matos-Pita, A.S., Nieto, A., Park, Y.C., Cheng, P.S., Li, W., Favis, R., Ricci, D., Poveda, A.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article